Patent · US Active

Methods for inhibiting conversion of choline to trimethylamine (TMA)

US11246844B2 · kind B2 · utility

0Cited by

5References

3Claims

0Family size

Assignees

The Procter & Gamble Company · US
The Cleveland Clinic Foundation · US

Inventors

Stanley L. Hazen · Pepper Pike, US
Jose Carlos Garcia-Garcia · Cincinnati, US
George Franklin Gerberick · Cincinnati, US
John August Wos · Cincinnati, US
Xiaodong Gu · Cleveland, US
Michael Reilly · Lebanon, US
Mark Robert Sivik · Lancaster, US
Jodie Michelle Reed · Loveland, US
David Blair Cody · Columbus, US

Key dates

Filing date	May 31, 2017
Grant date	Feb 15, 2022
Priority date	—
Expiry date	May 31, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO by providing a composition comprising a compound set forth in Formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.